Authors:
TANI H
OOURA T
KAMIDATE T
KAMATAKI T
WATANABE H
Citation: H. Tani et al., SEPARATION OF MICROSOMAL CYTOCHROME B(5) VIA PHASE-SEPARATION IN A MIXED-SOLUTION OF TRITON X-114 AND CHARGED DEXTRAN, Journal of chromatography B. Biomedical sciences and applications, 708(1-2), 1998, pp. 294-298
Citation: M. Sawada et T. Kamataki, GENETICALLY-ENGINEERED CELLS STABLY EXPRESSING CYTOCHROME-P450 AND THEIR APPLICATION TO MUTAGEN ASSAYS, Mutation research. Reviews in mutation research, 411(1), 1998, pp. 19-43
Citation: T. Mori et al., MOLECULAR-CLONING AND REGULATION OF A NOVEL GUINEA-PIG CYTOCHROME-P450 (CYP3A20) WHICH DIFFERS FROM GUINEA-PIG CYP3A14 IN ONLY 2 AMINO-ACID-RESIDUES, Biochemistry and molecular biology international, 44(6), 1998, pp. 1245-1253
Authors:
NUNOYA K
YOKOI T
KIMURA K
INOUE K
KODAMA T
FUNAYAMA M
NAGASHIMA K
FUNAE Y
GREEN C
KINOSHITA M
KAMATAKI T
Citation: K. Nunoya et al., A NEW DELETED ALLELE IN THE HUMAN CYTOCHROME-P450 2A6 (CYP2A6) GENE FOUND IN INDIVIDUALS SHOWING POOR METABOLIC CAPACITY TO COUMARIN AND (-CIS-3,5-DIMETHYL-2-(3-PYRIDYL)THIAZOLIDIN-4-ONE HYDROCHLORIDE (SM-12502)()), Pharmacogenetics, 8(3), 1998, pp. 239-249
Authors:
ANDO Y
SAKA H
ASAI G
SUGIURA S
SHIMOKATA K
KAMATAKI T
Citation: Y. Ando et al., UGT1A1 GENOTYPES AND GLUCURONIDATION OF SN-38, THE ACTIVE METABOLITE OF IRINOTECAN, Annals of oncology, 9(8), 1998, pp. 845-847
Citation: T. Yokoi et T. Kamataki, GENETIC-POLYMORPHISM OF DRUG-METABOLIZING-ENZYMES - NEW MUTATIONS IN CYP2D6 AND CYP2A6 GENES IN JAPANESE, Pharmaceutical research, 15(4), 1998, pp. 517-524
Authors:
TAKASUNA K
HAGIWARA T
HIROHASHI M
KATO M
NOMURA M
NAGAI E
YOKOI T
KAMATAKI T
Citation: K. Takasuna et al., INHIBITION OF INTESTINAL MICROFLORA BETA-GLUCURONIDASE MODIFIES THE DISTRIBUTION OF THE ACTIVE METABOLITE OF THE ANTITUMOR AGENT, IRINOTECAN HYDROCHLORIDE (CPT-11) IN RATS, Cancer chemotherapy and pharmacology, 42(4), 1998, pp. 280-286
Authors:
NAKAMURA K
YOKOI T
KODAMA T
INOUE K
NAGASHIMA K
SHIMADA N
SHIMIZU T
KAMATAKI T
Citation: K. Nakamura et al., OXIDATION OF HISTAMINE H1 ANTAGONIST MEQUITAZINE IS CATALYZED BY CYTOCHROME-P450 2D6 IN HUMAN LIVER-MICROSOMES, Naunyn-Schmiedeberg's archives of pharmacology, 358(1), 1998, pp. 435-435
Citation: K. Takasuna et al., INVOLVEMENT OF BETA-GLYCURONIDASE IN INTESTINAL MICROFLORA IN THE INTESTINAL TOXICITY OF THE ANTITUMOR CAMPTOTHECIN DERIVATIVE, IRINOTECAN (CPT-11), IN RATS, Naunyn-Schmiedeberg's archives of pharmacology, 358(1), 1998, pp. 5434-5434
Authors:
NAKAMURA K
YOKOI T
KODAMA T
INOUE K
NAGASHIMA K
SHIMADA N
SHIMIZU T
KAMATAKI T
Citation: K. Nakamura et al., OXIDATION OF HISTAMINE H1 ANTAGONIST MEQUITAZINE IS CATALYZED BY CYTOCHROME-P450 2D6 IN HUMAN LIVER-MICROSOMES, The Journal of pharmacology and experimental therapeutics, 284(2), 1998, pp. 437-442
Authors:
TASAKI T
NAKAMURA A
ITOH S
OHASHI K
YAMAMOTO Y
MASUDA M
IWATA H
KAZUSAKA A
KAMATAKI T
FUJITA S
Citation: T. Tasaki et al., EXPRESSION AND CHARACTERIZATION OF DOG CYP2D15 USING BACULOVIRUS EXPRESSION SYSTEM, Journal of Biochemistry, 123(1), 1998, pp. 162-168
Authors:
SUZUKI A
KUSHIDA H
IWATA H
WATANABE M
NOHMI T
FUJITA K
GONZALEZ FJ
KAMATAKI T
Citation: A. Suzuki et al., ESTABLISHMENT OF A SALMONELLA TESTER STRAIN HIGHLY SENSITIVE TO MUTAGENIC HETEROCYCLIC AMINES, Cancer research, 58(9), 1998, pp. 1833-1838
Authors:
ANDO Y
SHIMIZU T
NAKAMURA K
MUSHIRODA T
NAKAGAWA T
KODAMA T
KAMATAKI T
Citation: Y. Ando et al., POTENT AND NONSPECIFIC INHIBITION OF CYTOCHROME-P450 BY JM216, A NEW ORAL PLATINUM AGENT, British Journal of Cancer, 78(9), 1998, pp. 1170-1174
Authors:
IWATA H
FUJITA K
KUSHIDA H
SUZUKI A
KONNO Y
NAKAMURA K
FUJINO A
KAMATAKI T
Citation: H. Iwata et al., HIGH CATALYTIC ACTIVITY OF HUMAN CYTOCHROME-P450 COEXPRESSED WITH HUMAN NADPH-CYTOCHROME P450 REDUCTASE IN ESCHERICHIA-COLI, Biochemical pharmacology, 55(8), 1998, pp. 1315-1325
Authors:
YAMADA A
FUJITA K
YOKOI T
MUTO S
SUZUKI A
GONDO Y
KATSUKI M
KAMATAKI T
Citation: A. Yamada et al., IN-VIVO DETECTION OF MUTATIONS INDUCED BY AFLATOXIN B-1 USING HUMAN CYP3A7 HITEC HYBRID MICE/, Biochemical and biophysical research communications (Print), 250(1), 1998, pp. 150-153
Citation: Y. Takahashi et al., SILENCING OF CYP1A1 EXPRESSION IN RABBITS BY DNA METHYLATION, Biochemical and biophysical research communications, 247(2), 1998, pp. 383-386
Authors:
NAKURA H
ITOH S
KUSANO H
ISHIZONE H
KAMATAKI T
Citation: H. Nakura et al., OPPOSITE EFFECTS OF ISONIAZID AND FASTING ON THE EXPRESSION OF CYP2E1PROTEIN AND MESSENGER-RNA IN-HOUSE MUSK SHREW (SUNCUS-MURINUS), Biochemistry and molecular biology international, 41(2), 1997, pp. 293-301
Authors:
TANI H
SAITOH T
KAMIDATE T
KAMATAKI T
WATANABE H
Citation: H. Tani et al., SELECTIVE SOLUBILIZATION OF MICROSOMAL ELECTRON-TRANSFER PROTEINS WITH ALKYLGLUCOSIDE, Analytical sciences, 13(5), 1997, pp. 747-751
Authors:
FUJITA K
IWATA H
KUSHIDA H
SUZUKI A
NAKAMURA K
KONNO Y
KAMATAKI T
Citation: K. Fujita et al., SIMULTANEOUS EXPRESSION OF HUMAN P450 AND HUMAN NADPH-P450 REDUCTASE IN ESCHERICHIA-COLI - EXTREMELY HIGH-ACTIVITY TO METABOLIZE DRUGS, The FASEB journal, 11(9), 1997, pp. 119-119
Authors:
GILLAM EMJ
WUNSCH RM
UENG YF
SHIMADA T
PARIKH A
KAMATAKI T
GUENGERICH FP
Citation: Emj. Gillam et al., EXPRESSION OF P450 3A7 IN ESCHERICHIA-COLI - EFFECTS OF 5 MODIFICATION AND CATALYTIC CHARACTERIZATION OF THE RECOMBINANT ENZYME, The FASEB journal, 11(9), 1997, pp. 144-144
Authors:
NAKAYAMA K
SUDO Y
SASAKI Y
IWATA H
KAMATAKI T
Citation: K. Nakayama et al., TRANSCRIPTIONAL REGULATION OF CYP3A16 GENE - ANALYSIS BY DIRECT-INJECTION OF DNA INTO MOUSE-LIVER, The FASEB journal, 11(9), 1997, pp. 272-272